Multitude Therapeutics
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
3698 Haven Ave Ste A, Redwood City, Cali...Revenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Multitude Therapeutics
Multitude Therapeutics specializes in target discovery through its unique MabArray platform. The company focuses on developing innovative therapeutic solutions. Their services are aimed at clients in the biopharmaceutical industry. Multitude Therapeutics is committed to advancing healthcare through cutting-edge technology.Explore more
Multitude Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Multitude Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Multitude Therapeutics
Click to see if Multitude Therapeutics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Multitude Therapeutics has new funding data
Product Launch: Get notified when Multitude Therapeutics launches new products
Earning: See what the market has to say on Multitude Therapeutics recently announced quarterly report
Check out if Multitude Therapeutics is spiking on competitors!
Multitude Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check if Multitude Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Multitude Therapeutics
Compare insights from companies similar to Multitude Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Multitude Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Multitude Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Multitude Therapeutics.
Multitude Therapeutics Tech Stack
A closer look at the technologies used by Multitude Therapeutics
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Partnership
Information Security
Partnership
Multitude Therapeutics News & Media
Multitude Therapeutics Announces Promising Interim Phase I/II Results from the Ongoing First-in-Human Study Evaluating its CD44v9-directed Antibody-Drug-Conjugate, AMT-116, in Heavily Pretreated EGFR Wild-type Non-Small Cell Lung Cancer (NSCLC) and Other Advanced Solid Tumors at the 2025 ESMO Annual Meeting
AMT-116 is a potential first-in-class CD44v9-directed Topoisomerase I inhibitor-based ADC AMT-116 demonstrated a favorable safety profile, with manageable hematologic and Gastrointestinal toxicities Promising efficacies were observed in patients with heavily pretreated EGFR Wild-type...Adcendo ApS and Multitude Therapeutics Inc. Announce Global Development and Commercialization Agreement on First-in-class ADC Drug Candidate Targeting Tissue Factor
COPENHAGEN, Denmark and SHANGHAI, Aug. 20, 2024 /PRNewswire/ -- Adcendo ApS ("Adcendo") and Multitude Therapeutics Inc. ("Multitude") jointly announced today that they have signed a licensing agreement for the development of a novel, highly differentiated antibody-drug conjugate (ADC)...WuXi XDC Enters into Partnership with Multitude Therapeutics and HySlink Therapeutics, Novel Linker-Payload Technology Enabling Clients to Accelerate ADC Discovery and Development
SHANGHAI, Jan. 31, 2024 /PRNewswire/ -- WuXi XDC (2268.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on ADC and the other types of bioconjugate market; and Multitude Therapeutics, a clinical stage biotechnology company renowned for ADC platform technologies, announced today that they have reached a comprehensive partnership in drug-linker technology, which is co-developed with HySlink Therapeutics ("HySlink"), and CRDMO services spanning from
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Multitude Therapeutics
Sign Up For FreeTo access detailed company insights
Multitude Therapeutics specializes in target discovery through its unique MabArray platform. The company focuses on developing innovative therapeutic solutions. Their services are aimed at clients in the biopharmaceutical industry. Multitude Therapeutics is committed to advancing healthcare through cutting-edge technology.... Read More
